Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation

被引:546
作者
Palacios, EH
Weiss, A
机构
[1] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA
关键词
TCR; CSK; CD45; tyrosine phosphorylation;
D O I
10.1038/sj.onc.1208074
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The function of the Src-family kinases (SFKs) Lck and Fyn in T cells has been intensively studied over the past 15 years. Ani mal models and cell line studies both indicate a critical role for Lck and Fyn in proximal T-cell antigen receptor (TCR) signal transduction. Recruited SFKs phosphorylate TCR ITAMs (immunoreceptor tyrosine-based activation motifs) in the CD3 and zeta chains, which then serve as docking sites for Syk-family kinases. SFKs then phosphorylate and activate the recruited Syk-family kinase. Lck and Fyn are spatially segregated in cell membranes due to differential lipid raft localization, and may undergo sequential activation. In addition to the CD4 and CD8 coreceptors, a recently described adaptor, Unc119, may link SFKs to the TCR. CD45 and Csk provide positive and negative regulatory control of SFK functions, respectively, and Csk is constitutively bound to the transmembrane adapter protein, PAG/Cbp. TCR-based signaling is required at several stages of T-cell development, including at least pre-TCR signaling, positive selection, peripheral maintenance of naive T cells, and lymphopenia-induced proliferation. SFKs are required for each of these TCR-based signals, and Lck seems to be the major contributor.
引用
收藏
页码:7990 / 8000
页数:11
相关论文
共 101 条
  • [1] THYMIC TUMORIGENESIS INDUCED BY OVEREXPRESSION OF P56LCK
    ABRAHAM, KM
    LEVIN, SD
    MARTH, JD
    FORBUSH, KA
    PERLMUTTER, RM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (09) : 3977 - 3981
  • [2] DELAYED THYMOCYTE DEVELOPMENT INDUCED BY AUGMENTED EXPRESSION OF P56LCK
    ABRAHAM, KM
    LEVIN, SD
    MARTH, JD
    FORBUSH, KA
    PERLMUTTER, RM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (06) : 1421 - 1432
  • [3] INHIBITION OF T-CELL RECEPTOR BETA-CHAIN GENE REARRANGEMENT BY OVEREXPRESSION OF THE NONRECEPTOR PROTEIN TYROSINE KINASE-P56LCK
    ANDERSON, SJ
    ABRAHAM, KM
    NAKAYAMA, T
    SINGER, A
    PERLMUTTER, RM
    [J]. EMBO JOURNAL, 1992, 11 (13) : 4877 - 4886
  • [4] DEFECTIVE T-CELL RECEPTOR SIGNALING IN MICE LACKING THE THYMIC ISOFORM OF P59(FYN)
    APPLEBY, MW
    GROSS, JA
    COOKE, MP
    LEVIN, SD
    QIAN, X
    PERLMUTTER, RM
    [J]. CELL, 1992, 70 (05) : 751 - 763
  • [5] Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein (WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASp effector function and T cell activation
    Bodour, K
    Zhang, JY
    Shi, F
    Leng, S
    Collins, M
    Siminovitch, KA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (01) : 99 - 111
  • [6] Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase Csk and is involved in regulation of T cell activation
    Brdicka, T
    Pavilstová, D
    Leo, A
    Bruyns, E
    Korínek, V
    Angelisová, P
    Scherer, J
    Shevchenko, A
    Shevchenko, A
    Hilgert, I
    Cerny, J
    Drbal, K
    Kuramitsu, Y
    Kornacker, B
    Horejsí, V
    Schraven, B
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (09) : 1591 - 1604
  • [7] CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4(+)CD8(+) thymocytes, and in B cell maturation
    Byth, KF
    Conroy, LA
    Howlett, S
    Smith, AJH
    May, J
    Alexander, DR
    Holmes, N
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) : 1707 - 1718
  • [8] CHAN AC, 1994, J IMMUNOL, V152, P4758
  • [9] The Syk family of protein tyrosine kinases in T-cell activation and development
    Chu, DH
    Morita, CT
    Weiss, A
    [J]. IMMUNOLOGICAL REVIEWS, 1998, 165 : 167 - 180
  • [10] Chu DH, 1999, J IMMUNOL, V163, P2610